Nutrition 21 to Supply Four New Products to Walgreens

PURCHASE, N.Y., July 22 /PRNewswire-FirstCall/ -- Nutrition 21, Inc.
(Nasdaq: NXXI), a developer and marketer of nutritional supplements that help
consumers manage blood sugar levels, improve cardiovascular health, enhance
memory and address chronic joint pain, today announced its agreement with
Walgreens to supply three new chromium picolinate products for the Finest
Natural(R) retail brand and one product for the Walgreens Gold Seal Private
Label. These products are anticipated to be available late this summer or
early fall.
Walgreens, one of the largest retailers in the United States, has 6,300
stores in 49 states. "Walgreens commitment is a major milestone in our move to
expand our retail nutrition supplement business by working with industry-
moving retailers to meet the growing needs of health-conscious consumers,"
said Michael Fink, co-Chief Operating Officer of Nutrition 21. "It also
reflects the growing appreciation by retailers of Nutrition 21's continuing
commitment to develop and market proprietary and clinically substantiated
nutraceuticals that address significant health care concerns. We anticipate
beginning to receive revenues from these new products during the quarter
ending September 30, 2008."
About Nutrition 21
Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a
nutritional bioscience company and the maker of chromium picolinate-based and
omega-3 fish oil-based supplements with health benefits substantiated by
clinical research. Nutrition 21 holds more than 30 patents for nutrition
products and uses. Nutrition 21's portfolio of health and wellness brands
include: Chromax(R), Core4Life Advanced Memory Formula(TM), Diabetes
Essentials(TM), Iceland Health(R) Maximum Strength Omega-3 and Iceland
Health(R) Joint Relief. The company also manufactures private label
supplements and ingredients for third parties. Nutrition 21 distributes its
products nationally through more than 29,000 major food, drug and super center
retailers as well as internationally. For more information please visit
http://www.nutrition21.com.
Safe Harbor Provision
This press release may contain certain forward-looking statements. The
words "believe," "expect," "anticipate" and other similar expressions
generally identify forward-looking statements. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as
of their dates. These forward-looking statements are based largely on the
Company's current expectations and are subject to a number of risks and
uncertainties, including without limitation: the effect of the expiration of
patents; regulatory issues; uncertainty in the outcomes of clinical trials;
changes in external market factors; changes in the Company's business or
growth strategy or an inability to execute its strategy due to changes in its
industry or the economy generally; the emergence of new or growing
competitors; various other competitive factors; and other risks and
uncertainties indicated from time to time in the Company's filings with the
Securities and Exchange Commission, including its Form 10-K/A for the year
ended June 30, 2007. Actual results could differ materially from the results
referred to in the forward-looking statements. In light of these risks and
uncertainties, there can be no assurance that the results referred to in the
forward-looking statements contained in this press release will in fact occur.
Additionally, the Company makes no commitment to disclose any revisions to
forward-looking statements, or any facts, events or circumstances after the
date hereof that may bear upon forward-looking statements.
CONTACT: Joe Diaz
Lytham Partners, LLC
(602) 889-9700

SOURCE Nutrition 21, Inc.

Joe Diaz of Lytham Partners, LLC, +1-602-889-9700, for Nutrition 21, Inc.